Proscia
Rewiring pathology for precision medicine
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- proscia.com
- Total Funding
- $118.3M
- Last Round
- $50.0M Series CMar 2025
- Rounds
- 4
About
Proscia is a Philadelphia-based digital pathology software company founded in 2014 by David West, Coleman Stavish, and Nathan Buchbinder. The company's Concentriq platform is an enterprise digital pathology system used by more than 12,000 pathologists and scientists daily at reference labs, academic medical centers, CROs, and 16 of the top 20 global pharma companies. Concentriq offers purpose-built products for life sciences research, anatomic pathology digitization, and FDA-cleared primary diagnosis. Proscia also offers Aperture, a precision medicine solution for drug development and real-world evidence generation.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Mar 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...